Certain information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation ("MAR") as applied in the United Kingdom. Upon publication of this Announcement, this information is now considered to be in the public domain.

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

Exercise of Options

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that the Company has received a request to exercise options over 30,000 ordinary shares of 1.5p each in the Company. The request has been satisfied by the allotment on 20 December 2024 of new ordinary shares issued under the Company's allotment authorities.

The New Ordinary Shares rank pari passu in all respects with the Company's existing Ordinary Shares. An application will be made to the London Stock Exchange for the 30,000 New Ordinary Shares (the "New Ordinary Shares") to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00am on or around 31 December 2024.

The options, the subject of the request, had an exercise price of 9.5 pence per share.

Admission of shares and total voting rights

Following Admission, the total issued share capital of the Company will consist of 52,035,932 ordinary shares.  As each ordinary share carries the right to one vote, the total number of voting rights in the Company will be 52,035,932.  This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information contact:

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.